Prot #FRF4998g: An Open-Label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma.
- Singhal, Seema (PD/PI)
Project: Research project
Project: Research project